Research Article

Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors

Table 1

Structures and analytical data of tripeptides synthesized.

PeptideStructureHPLCESI-MS Yield
tRfoundcalc

S1GMD10.50322.08321.1075%
S2ERA9.99375.3374.1980 %
S3GHE8.08342.14341.1367%
S4GER10.00361.17360.1880%
S5DRC9.89393.20392.1562%
S6ARA10.46317.24316.1968%
S7PER8.87401.40400.2181%
S8KHI10.98397.11396.2580%
S9AER11.00375.32374.1975%
S10AGR9.03303.34302.1779%
E1SRH8.95399.30398.2068%
E2SWE8.04421.0420.1669%
E3IRT8.03389.3388.2476%
E4SMD8.00342.16351.1178%
E5GRN8.43346.2345.1865%
E6SHE8.68372.17371.1476%
E7SQE8.45363.17362.1467%
E8SMH9.46374.26373.1475%
E9ARM8.03377.6376.1977%
E10AQE9.97347.0346.1576%

tR: peptide retention time.